Z
Zhibo Jiang
Researcher at Peking Union Medical College
Publications - 13
Citations - 236
Zhibo Jiang is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Chemistry & Gene. The author has an hindex of 6, co-authored 9 publications receiving 111 citations.
Papers
More filters
Journal ArticleDOI
Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice.
TL;DR: Investigation into effects of butyrate on high‐fat diet‐fed ApoE−/− mice after 16 weeks' administration finds no change in the effects of the metabolite on atherosclerosis.
Journal ArticleDOI
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
Xingxing Li,Chunyan Su,Zhibo Jiang,Yuxin Yang,Yue Zhang,Mengxia Yang,Xiumin Zhang,Yu Du,Jin Zhang,Li Wang,Jian-Dong Jiang,Bin Hong +11 more
TL;DR: In this paper, BBR attenuated TMA/TMAO production in the C57BL/6J and ApoE KO mice fed with choline-supplemented chow diet, and mitigated atherosclerotic lesion areas in ApOEKO mice.
Journal ArticleDOI
Binding of a biosynthetic intermediate to AtrA modulates the production of lidamycin by Streptomyces globisporus.
Xingxing Li,Tengfei Yu,Qing He,Kenneth J. McDowall,Bingya Jiang,Zhibo Jiang,Linzhuan Wu,Guangwei Li,Qinglian Li,Songmei Wang,Yuanyuan Shi,Lifei Wang,Bin Hong +12 more
TL;DR: It is shown that for the production of lidamycin by Streptomyces globisporus that negative feedback can extend to a point higher in the regulatory cascade, and that the feedback to the pleiotropic regulator AtrA is likely to provide a mechanism for coordinating theProduction of lid amycin with that of other secondary metabolites.
Journal ArticleDOI
Complete genome sequence of Streptomyces globisporus C-1027, the producer of an enediyne antibiotic lidamycin.
TL;DR: The genome sequence of S. globisporus C-1027 will enable us to disclose biosynthetic pathways of these secondary metabolites and discover new natural products with potential applications notably in human health.
Journal ArticleDOI
Improving the N-terminal diversity of sansanmycin through mutasynthesis.
Yuanyuan Shi,Zhibo Jiang,Xuan Lei,Ningning Zhang,Qiang Cai,Qinglian Li,Lifei Wang,Shuyi Si,Yunying Xie,Bin Hong +9 more
TL;DR: SsaX is demonstrated to be responsible for the biosynthesis of m-Tyr in vivo by gene deletion and complementation and indicated that ssaX deletion mutant SS/XKO was a suitable host to expand the diversity of the N-terminus of UPAs, with potential to yield more novel compounds with improved activity and/or other properties.